MedTrace Logo

Red Clover Isoflavones in Postmenopausal Women With Urge Urinary Incontinence and Overactive Bladder

NCT05013593 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2023-04-26

No results posted yet for this study

Summary

The purpose of this study is to investigate the effect of red clover isoflavones in postmenopausal women with and without urge urinary incontinence and overactive bladder

Conditions

Interventions

DIETARY_SUPPLEMENT

Red Clover Extract (RCE)

Red clover extract containing isoflavones Formononetin and biochanin A together with a heterogenous culture of probiotic lactic acid bacteria, and a natural sugar free raspberry/orange flavor. Isoflavone amount is 57.45 mg isoflavones daily (55.84 mg aglycones daily), in 70 ml red clover extract (35 ml twice daily, morning and evening together with a meal)

OTHER

Placebo (PL)

Placebo containing water, brown coloring, and natural sugar free raspberry/orange flavor.

Sponsors & Collaborators

  • University of Aarhus

    collaborator OTHER

  • Regionshospital Nordjylland

    lead OTHER_GOV

Principal Investigators

  • Annemarie B Villadsen · Regionshospital Nordjylland

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-15
Primary Completion
2021-10-20
Completion
2021-10-20

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05013593 on ClinicalTrials.gov